Literature DB >> 20727996

Epidermal growth factor regulates PAI-1 expression via activation of the transcription factor Elk-1.

Paulina Wyrzykowska1, Krystyna Stalińska, Mateusz Wawro, Jakub Kochan, Aneta Kasza.   

Abstract

PAI-1 (plasminogen activator inhibitor-1) in breast cancer cells is involved in tumour development and metastasis of breast cancer cells. PAI-1 function and the regulation of its expression have been precisely investigated. Here we report that EGF, which promotes breast cancer tumour growth and survival, rapidly induces PAI-1 expression in the breast adenocarcinoma cell line MCF-7 through the activation of the transcription factor Elk-1. We have found that the PAI-1 promoter fragment (-140 to +173) containing the Ets consensus binding site is activated by Elk-1. Chromatin immunoprecipitation analysis confirms in vivo binding of Elk-1 to the PAI-1 promoter and demonstrates that Elk-1 phosphorylation on the Ets binding site is EGF-dependent.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20727996     DOI: 10.1016/j.bbagrm.2010.08.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  A novel nonconsensus xenobiotic response element capable of mediating aryl hydrocarbon receptor-dependent gene expression.

Authors:  Gengming Huang; Cornelis J Elferink
Journal:  Mol Pharmacol       Date:  2011-11-23       Impact factor: 4.436

2.  The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling.

Authors:  Kaku Goto; Wenyu Lin; Leiliang Zhang; Nikolaus Jilg; Run-Xuan Shao; Esperance A K Schaefer; Hong Zhao; Dahlene N Fusco; Lee F Peng; Naoya Kato; Raymond T Chung
Journal:  J Hepatol       Date:  2013-07-02       Impact factor: 25.083

3.  EGF activates TTP expression by activation of ELK-1 and EGR-1 transcription factors.

Authors:  Magdalena Florkowska; Piotr Tymoszuk; Aleksandra Balwierz; Anna Skucha; Jakub Kochan; Mateusz Wawro; Krystyna Stalinska; Aneta Kasza
Journal:  BMC Mol Biol       Date:  2012-03-20       Impact factor: 2.946

4.  Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs.

Authors:  Hatice U Osmanbeyoglu; Eneda Toska; Carmen Chan; José Baselga; Christina S Leslie
Journal:  Nat Commun       Date:  2017-01-31       Impact factor: 14.919

5.  NFAT5 directs hyperosmotic stress-induced fibrin deposition and macrophage infiltration via PAI-1 in endothelium.

Authors:  Pingping Ma; Guang Li; Xiaorui Jiang; Xinkun Shen; Hong Li; Li Yang; Wanqian Liu
Journal:  Aging (Albany NY)       Date:  2020-12-19       Impact factor: 5.682

Review 6.  Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets.

Authors:  Ralf-Peter Czekay; Dong-Joo Cheon; Rohan Samarakoon; Stacie M Kutz; Paul J Higgins
Journal:  Cancers (Basel)       Date:  2022-02-27       Impact factor: 6.639

7.  Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A.

Authors:  H-C Yu; M-H Hung; Y-L Chen; P-Y Chu; C-Y Wang; T-T Chao; C-Y Liu; C-W Shiau; K-F Chen
Journal:  Cell Death Dis       Date:  2014-07-31       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.